FORTUNATO, Fernanda
 Distribuzione geografica
Continente #
NA - Nord America 381
EU - Europa 111
AS - Asia 100
AF - Africa 2
Totale 594
Nazione #
US - Stati Uniti d'America 380
IT - Italia 60
CN - Cina 43
SG - Singapore 41
DE - Germania 20
ID - Indonesia 11
GB - Regno Unito 9
FI - Finlandia 7
SE - Svezia 4
CZ - Repubblica Ceca 3
SI - Slovenia 3
UA - Ucraina 3
DZ - Algeria 2
VN - Vietnam 2
BD - Bangladesh 1
BE - Belgio 1
CA - Canada 1
IN - India 1
NL - Olanda 1
TR - Turchia 1
Totale 594
Città #
Chandler 66
Fairfield 54
Ashburn 37
Ferrara 30
Singapore 26
Beijing 18
Seattle 15
Cambridge 14
Shanghai 14
Woodbridge 14
Houston 12
New York 12
Jakarta 11
Bremen 9
Princeton 9
Wilmington 9
Munich 8
San Diego 8
Los Angeles 7
Milan 6
Falls Church 5
Helsinki 5
Santa Clara 5
Ann Arbor 4
Boardman 4
Bologna 3
Brno 3
Jacksonville 3
Rome 3
Dearborn 2
Dong Ket 2
Guangzhou 2
Hounslow 2
Nanjing 2
Shenyang 2
Addison 1
Amsterdam 1
Chicago 1
Cingoli 1
Espoo 1
Ferrara di Monte Baldo 1
Hyderabad 1
Izmir 1
Kilburn 1
Lacco Ameno 1
Lappeenranta 1
Leawood 1
London 1
Lowell 1
Norwalk 1
Orange 1
Padova 1
Redwood City 1
San Mateo 1
Toronto 1
Washington 1
Totale 447
Nome #
A CMT2 family carrying the P7R mutation in the N- terminal region of the HSPB1 gene 82
DMD gene molecular genetic characterization in Eastern Europe and non European countries 78
Report of a novel ATP7A mutation causing distal motor neuropathy 75
Ethnicity-related DMD Genotype Landscapes in European and Non-European Countries 70
Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection 62
Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Response in Duchenne Muscular Dystrophy 52
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study 49
ISS-NIA ITALIAN COHORT: NEW ANTI-HIV INHIBITORS IN PATIENTS EXPERIENCED TO IP, NRTI, NNRTI 30
Three-years follow up of raltegravir and/or maraviroc-based regimens in patients experienced to PI, NRTI, NNRTI. Update from the ISS-NIA cohort 29
Rare diseases' genetic newborn screening as the gateway to future genomic medicine: the Screen4Care EU-IMI project 20
AFG3L2 Biallelic Mutation: Clinical Heterogeneity in Two Italian Patients 17
TeleNEwCARe: An Italian case-control telegenetics study in patients with Hereditary NEuromuscular and CARdiac diseases 15
Genetic newborn screening and digital technologies: A project protocol based on a dual approach to shorten the rare diseases diagnostic path in Europe 13
The DMD gene and therapeutic approaches to restore dystrophin 11
DMD deletions underlining mild dystrophinopathies: literature review highlights phenotype-related mutation clusters and provides insights about genetic mechanisms and prognosis 10
Digital health and Clinical Patient Management System (CPMS) platform utility for data sharing of neuromuscular patients: the Italian EURO-NMD experience 9
mRNA in situ hybridization exhibits unbalanced nuclear/cytoplasmic dystrophin transcript repartition in Duchenne myogenic cells and skeletal muscle biopsies 7
Totale 629
Categoria #
all - tutte 5.660
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.660


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202083 0 0 0 4 5 8 12 8 19 14 9 4
2020/2021102 1 9 0 12 1 12 7 18 7 8 18 9
2021/202293 1 13 0 2 8 6 1 0 12 11 4 35
2022/2023131 12 22 4 13 24 11 5 11 23 1 3 2
2023/2024126 7 11 5 1 11 22 4 10 15 4 3 33
2024/202579 20 13 37 9 0 0 0 0 0 0 0 0
Totale 629